| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Mutual Fund |
| Shares
Out: |
21,572,000 |
| Market
Cap: |
279.79(M) |
| Last
Volume: |
98,778 |
Avg
Vol: |
98,502 |
| 52
Week Range: |
$11.35 - $14.33 |
|
| Level
I Sector: |
Financials |
| Level
II Sector: |
Financial Services |
| Level
III Sector: |
Closed - End Fund - Equity |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 14.6 |
| Insider 6 Months : 15.9 |
| Insider 3/6 Months : 30.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tekla Life Sciences Investors is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. The Fund invests primarily in securities of public and private companies.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
292,925 |
294,925 |
317,021 |
317,021 |
| Total Buy Value |
$3,793,485 |
$3,820,853 |
$4,098,175 |
$4,098,175 |
| Total People Bought |
2 |
4 |
5 |
5 |
| Total Buy Transactions |
7 |
9 |
11 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-30 |
2023-10-29 |
2023-04-30 |
2022-04-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Weinstein Boaz |
10% Owner |
– – • |
2024-04-25 |
4 |
B |
$12.99 |
$1,267,486 |
I/I |
97,574 |
2,905,298 |
1.5 |
- |
|
| Weinstein Boaz |
10% Owner |
– – • |
2024-04-24 |
4 |
B |
$13.12 |
$269,340 |
I/I |
20,529 |
2,807,724 |
1.5 |
- |
|
| Weinstein Boaz |
10% Owner |
– – • |
2024-04-23 |
4 |
B |
$13.15 |
$633,869 |
I/I |
48,203 |
2,787,195 |
1.5 |
-2% |
|
| Weinstein Boaz |
10% Owner |
– – • |
2024-04-22 |
4 |
B |
$12.88 |
$26,043 |
I/I |
2,022 |
2,738,992 |
1.5 |
-0% |
|
| Weinstein Boaz |
10% Owner |
– – • |
2024-04-19 |
4 |
B |
$12.84 |
$545,174 |
I/I |
42,459 |
2,736,970 |
1.5 |
1% |
|
| Weinstein Boaz |
10% Owner |
– – • |
2024-04-18 |
4 |
B |
$12.80 |
$1,046,246 |
I/I |
81,738 |
2,694,511 |
1.5 |
1% |
|
| Weinstein Boaz |
10% Owner |
– – • |
2024-04-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,694,511 |
|
1% |
|
| Goetz Kathleen |
Director |
– • – |
2024-04-09 |
4 |
B |
$13.32 |
$5,327 |
D/D |
400 |
1,085 |
2.39 |
-3% |
|
| Reit Todd |
Director |
– • – |
2024-01-02 |
4 |
B |
$13.80 |
$13,798 |
D/D |
1,000 |
1,000 |
2.39 |
-6% |
|
| Maher Bill |
Director |
– • – |
2023-12-28 |
4 |
B |
$13.57 |
$13,570 |
D/D |
1,000 |
1,000 |
2.39 |
-4% |
|
| Omstead Daniel R |
President |
• • – |
2023-09-25 |
4 |
B |
$12.39 |
$125,116 |
D/D |
10,096 |
197,518 |
2.81 |
12% |
|
| Omstead Daniel R |
President |
• • – |
2023-09-20 |
4 |
B |
$12.68 |
$152,206 |
D/D |
12,000 |
187,422 |
2.81 |
9% |
|
| Goetz Kathleen |
Director |
– • – |
2022-03-23 |
4 |
B |
$16.27 |
$1,502 |
D/D |
92 |
685 |
2.31 |
-8% |
|
| Goetz Kathleen |
Director |
– • – |
2022-01-26 |
4 |
B |
$17.54 |
$10,404 |
D/D |
593 |
593 |
2.39 |
-18% |
|
| Omstead Daniel R |
President |
• • – |
2021-08-11 |
4 |
B |
$21.63 |
$138,497 |
D/D |
6,403 |
146,489 |
2.81 |
-11% |
|
| Omstead Daniel R |
President |
• • – |
2020-10-26 |
4 |
B |
$17.52 |
$108,204 |
D/D |
6,175 |
131,836 |
2.81 |
11% |
|
| Omstead Daniel R |
President |
• • – |
2020-10-21 |
4 |
B |
$17.75 |
$105,606 |
D/D |
5,950 |
125,661 |
2.81 |
17% |
|
| Bailey Jeffrey Allen |
Director |
– • – |
2020-09-22 |
4 |
B |
$17.28 |
$10,022 |
D/D |
580 |
580 |
2.39 |
19% |
|
| Omstead Daniel R |
President |
• • – |
2020-05-21 |
4 |
B |
$17.74 |
$105,557 |
D/D |
5,950 |
114,821 |
2.81 |
-2% |
|
| Omstead Daniel R |
President |
• • – |
2020-03-17 |
4 |
B |
$13.27 |
$110,107 |
D/D |
8,300 |
105,814 |
2.81 |
41% |
|
| Kent Thomas M |
Director |
– • – |
2018-01-25 |
4 |
B |
$21.04 |
$27,348 |
D/D |
1,300 |
1,300 |
2.39 |
- |
|
| Stebbins Lucinda H |
Director |
– • – |
2015-06-29 |
4 |
S |
$28.17 |
$28,170 |
D/D |
(1,000) |
5,985 |
|
- |
|
| Reardon William S |
Director |
– • – |
2014-06-30 |
4 |
B |
$19.75 |
$3,950 |
D/D |
200 |
1,612 |
2.31 |
- |
|
| Reinhardt Uwe E |
Director |
– • – |
2014-06-24 |
4 |
OE |
$19.75 |
$14,852 |
D/D |
752 |
3,010 |
|
- |
|
| Omstead Daniel R |
President |
• • – |
2014-06-24 |
4 |
OE |
$19.75 |
$290,088 |
D/D |
14,688 |
58,757 |
|
- |
|
29 Records found
|
|
Page 1 of 2 |
|
|
0.02 (0.15%) 
